X8Q

[3-[2-(dimethylamino)ethyl]-1~{H}-indol-4-yl] dihydrogen phosphate


Toggle HydrogenToggle Labels

Chemical Component Summary

Name[3-[2-(dimethylamino)ethyl]-1~{H}-indol-4-yl] dihydrogen phosphate
Identifiers[3-[2-(dimethylamino)ethyl]-1~{H}-indol-4-yl] dihydrogen phosphate
FormulaC12 H17 N2 O4 P
Molecular Weight284.248
TypeNON-POLYMER
Isomeric SMILESCN(C)CCc1c[nH]c2c1c(ccc2)OP(=O)(O)O
InChIInChI=1S/C12H17N2O4P/c1-14(2)7-6-9-8-13-10-4-3-5-11(12(9)10)18-19(15,16)17/h3-5,8,13H,6-7H2,1-2H3,(H2,15,16,17)
InChIKeyQVDSEJDULKLHCG-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count36
Chiral Atom Count0
Bond Count37
Aromatic Bond Count10

Drug Info: DrugBank

DrugBank IDDB11664 
NamePsilocybin
Groups investigational
DescriptionPsilocybin has been investigated for the treatment of Anxiety and Stage IV Melanoma. In November, 2019, it was granted Breakthrough Therapy status by the FDA.
Synonyms
  • Psilocybine
  • Psilocybinum
  • Psilocybin
  • Psilocibina
Categories
  • Alkaloids
  • Central Nervous System Agents
  • Central Nervous System Depressants
  • Hallucinogens
  • Heterocyclic Compounds, Fused-Ring
CAS number520-52-5

Related Resource References

Resource NameReference
Pharos CHEMBL194378
PubChem 138543650, 10624
ChEMBL CHEMBL194378
ChEBI CHEBI:8614